We had quite a little debate internally if to mark this as price sensitive or not. Was a hard decision given this work underpins the upcoming Israeli trial, but in the end decided to err on the side of not marking it as price sensitive. Ultimately it is up to each investor to decide the value of this work to the company.
- Forums
- ASX - By Stock
- Ann: Bisantrene Preclinical Drug Study Published
We had quite a little debate internally if to mark this as price...
-
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.62 |
Change
-0.060(3.57%) |
Mkt cap ! $277.7M |
Open | High | Low | Value | Volume |
$1.68 | $1.68 | $1.61 | $48.74K | 29.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1025 | $1.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1025 | 1.620 |
1 | 9081 | 1.615 |
1 | 19208 | 1.610 |
1 | 6000 | 1.605 |
5 | 48812 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.640 | 100 | 1 |
1.650 | 571 | 1 |
1.675 | 8073 | 2 |
1.680 | 1166 | 2 |
1.700 | 6382 | 1 |
Last trade - 13.20pm 04/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |